The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Saudi Arabia is experiencing a boom in IPO activity, signaling the liberalization of its economy and a shift away from government-led privatizations that once dominated its investment market. The ...

A wave of partners are leaving blue-chip firms to join emerging funds or start their own — some still unannounced. Meet ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

What Budget 2025 can do to power India's GCC surge Budget 2025: Global Capability Centers (GCCs) have evolved into significant contributors to India's GDP. The upcoming Budget might play a crucial ...

Jaiprakash Power Ventures Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 10,780.49 Crore) operating in Power sector. Jaiprakash Power Ventures Ltd. key Products ...

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China ...